Pierre Larochelle
Pierre Larochelle
professeur de pharmacologie, université d Montréal
Verified email at ircm.qc.ca
Title
Cited by
Cited by
Year
Adverse events associated with prescription drug cost-sharing among poor and elderly persons
R Tamblyn, R Laprise, JA Hanley, M Abrahamowicz, S Scott, N Mayo, ...
Jama 285 (4), 421-429, 2001
10472001
Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of …
AA Leung, K Nerenberg, SS Daskalopoulou, K McBrien, KB Zarnke, ...
Canadian Journal of Cardiology 32 (5), 569-588, 2016
4092016
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
SS Daskalopoulou, DM Rabi, KB Zarnke, K Dasgupta, K Nerenberg, ...
Canadian Journal of Cardiology 31 (5), 549-568, 2015
4002015
1999 Canadian recommendations for the management of hypertension
RD Feldman, N Campbell, P Larochelle, P Bolli, ED Burgess, ...
Cmaj 161 (12 suppl), S1-S17, 1999
386*1999
The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
K Dasgupta, RR Quinn, KB Zarnke, DM Rabi, P Ravani, ...
Canadian Journal of Cardiology 30 (5), 485-501, 2014
3282014
Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.
EL Schiffrin, LY Deng, P Larochelle
Hypertension 23 (1), 83-91, 1994
3161994
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2–therapy
NA Khan, B Hemmelgarn, RJ Herman, CM Bell, JL Mahon, LA Leiter, ...
Canadian Journal of Cardiology 25 (5), 287-298, 2009
3062009
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2–therapy
DG Hackam, NA Khan, BR Hemmelgarn, SW Rabkin, RM Touyz, ...
Canadian Journal of Cardiology 26 (5), 249-258, 2010
2792010
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
DG Hackam, RR Quinn, P Ravani, DM Rabi, K Dasgupta, ...
Canadian Journal of Cardiology 29 (5), 528-542, 2013
2602013
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II–therapy
NA Khan, FA McAlister, SW Rabkin, R Padwal, RD Feldman, ...
Canadian Journal of Cardiology 22 (7), 583-593, 2006
2602006
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study
A Zanchetti, L Hansson, B Dahlöf, D Elmfeldt, S Kjeldsen, R Kolloch, ...
Journal of hypertension 19 (6), 1149-1159, 2001
2472001
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy
SS Daskalopoulou, NA Khan, RR Quinn, M Ruzicka, DW McKay, ...
Canadian Journal of Cardiology 28 (3), 270-287, 2012
2422012
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial
SE Kjeldsen, S Julius, G Mancia, GT McInnes, T Hua, MA Weber, A Coca, ...
Journal of hypertension 24 (7), 1405-1412, 2006
2272006
Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor …
EL Schiffrin, LY Deng, P Larochelle
American journal of hypertension 8 (3), 229-236, 1995
1581995
Role of tumor necrosis factor-α gene locus in obesity and obesity-associated hypertension in French Canadians
Z Pausova, B Deslauriers, D Gaudet, J Tremblay, TA Kotchen, ...
Hypertension 36 (1), 14-19, 2000
1552000
The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy
DM Rabi, SS Daskalopoulou, RS Padwal, NA Khan, SA Grover, ...
Canadian Journal of Cardiology 27 (4), 415-433. e2, 2011
1532011
Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients
J de Champlain, M Karas, P Nguyen, P Cartier, R Wistaff, CB Toal, ...
Journal of hypertension 16 (9), 1357-1369, 1998
1461998
Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients.
EL Schiffrin, LY Deng, P Larochelle
Journal of hypertension 10 (5), 437-444, 1992
1381992
Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
FH Leenen, TW Wilson, P Bolli, P Larochelle, M Myers, SP Handa, ...
The Canadian journal of cardiology 13 (10), 914-920, 1997
1361997
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2–therapy
NA Khan, B Hemmelgarn, RJ Herman, SW Rabkin, FA McAlister, CM Bell, ...
Canadian Journal of Cardiology 24 (6), 465-475, 2008
1332008
The system can't perform the operation now. Try again later.
Articles 1–20